Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis Fuels the Asia Pacific Acute Pancreatitis Market
Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis.
Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the Asia Pacific acute pancreatitis market.
Asia Pacific Acute Pancreatitis Market Overview
The Asia Pacific acute pancreatitis market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth is attributed to factors including rising cases of pancreatitis, researchers to develop a treatment for pancreatitis, and government efforts to raise awareness among the population. In addition, alcohol-related pancreatitis cases also fuel the growth of the market in the region. The prevalence of pancreatitis has shown an upward trend in recent years in China. According to a study titled “Burden of Pancreatitis and associated risk factors in China, 1990 to 2019,” published in 2022, alcohol consumption has become an important cause in the disease burden of pancreatitis in recent years in the country. In China, cases of alcoholic pancreatitis are significantly higher compared to 10 years ago. In the country, the number of pancreatitis cases was 380,018 in 1990 and 493,765 in 2019. From 1990 to 2019, the total number of deaths due to pancreatitis also increased, accounting for 8,976 in 1990 and 10,664 in 2019. In 2019, the number of deaths due to alcohol-related pancreatitis was 3,327.29 in the country, accounting for 31.20% of the total deaths due to pancreatitis.
Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Asia Pacific Acute Pancreatitis Market Segmentation
The Asia Pacific acute pancreatitis market is segmented offerings, causes, end user, and country.
Based on offerings, the Asia Pacific acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.
Based on method, the Asia Pacific acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.
Based on end user, the Asia Pacific acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Asia Pacific acute pancreatitis market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific acute pancreatitis market in 2022.
Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the Asia Pacific acute pancreatitis market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific acute pancreatitis market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific acute pancreatitis market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
- 1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 2.2 Asia Pacific Acute Pancreatitis Market, by Country (US$ Million)
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. Asia Pacific Acute Pancreatitis Market Landscape
- 4.1 Overview
- 5. Asia Pacific Acute Pancreatitis Market - Key Industry Dynamics
- 5.1 Key Market Drivers
- 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
- 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
- 5.2 Key Market Restraints
- 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
- 5.3 Key Market Opportunities
- 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
- 5.4 Future Trends
- 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
- 5.5 Impact Analysis:
- 6. Acute Pancreatitis Market - Asia Pacific Market Analysis
- 6.1 Asia Pacific Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
- 7. Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Offerings
- 7.1 Overview
- 7.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
- 7.3 Medications
- 7.3.1 Overview
- 7.3.2 Medications: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.1 Asia Pacific Acute Pancreatitis Market, by Medications, 2020–2030 (US$ Million)
- 7.4 Diagnosis
- 7.4.1 Overview
- 7.4.2 Diagnosis: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 7.4.2.1 Asia Pacific Acute Pancreatitis Market, by Diagnosis, 2020–2030 (US$ Million)
- 7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 8. Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Causes
- 8.1 Overview
- 8.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
- 8.3 Gallstones
- 8.3.1 Overview
- 8.3.2 Gallstones: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 8.4 Alcoholism
- 8.4.1 Overview
- 8.4.2 Alcoholism: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 8.5 Genetic Disorders
- 8.5.1 Overview
- 8.5.2 Genetic Disorders: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 8.6 Infections
- 8.6.1 Overview
- 8.6.2 Infections: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 9. Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 – by End User
- 9.1 Overview
- 9.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
- 9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- 10. Asia Pacific Acute Pancreatitis Market – Country Analysis
- 10.1 Overview
- 10.1.1.1 Asia Pacific Acute Pancreatitis Market, by Country
- 10.1.1.2 China
- 10.1.1.2.1 Overview
- 10.1.1.2.2 China: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.2.3 China: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
- 10.1.1.2.3.1 China: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
- 10.1.1.2.3.2 China: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
- 10.1.1.2.4 China: Asia Pacific Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
- 10.1.1.2.5 China: Asia Pacific Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
- 10.1.1.3 Japan
- 10.1.1.3.1 Overview
- 10.1.1.3.2 Japan: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.3.3 Japan: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
- 10.1.1.3.3.1 Japan: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
- 10.1.1.3.3.2 Japan: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
- 10.1.1.3.4 Japan: Asia Pacific Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
- 10.1.1.3.5 Japan: Asia Pacific Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
- 10.1.1.4 India
- 10.1.1.4.1 Overview
- 10.1.1.4.2 India: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.4.3 India: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
- 10.1.1.4.3.1 India: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
- 10.1.1.4.3.2 India: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
- 10.1.1.4.4 India: Asia Pacific Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
- 10.1.1.4.5 India: Asia Pacific Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
- 10.1.1.5 Australia
- 10.1.1.5.1 Overview
- 10.1.1.5.2 Australia: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.5.3 Australia: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
- 10.1.1.5.3.1 Australia: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
- 10.1.1.5.3.2 Australia: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
- 10.1.1.5.4 Australia: Asia Pacific Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
- 10.1.1.5.5 Australia: Asia Pacific Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
- 10.1.1.6 South Korea
- 10.1.1.6.1 Overview
- 10.1.1.6.2 South Korea: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.6.3 South Korea: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
- 10.1.1.6.3.1 South Korea: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
- 10.1.1.6.3.2 South Korea: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
- 10.1.1.6.4 South Korea: Asia Pacific Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
- 10.1.1.6.5 South Korea: Asia Pacific Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
- 10.1.1.7 Rest of Asia Pacific
- 10.1.1.7.1 Overview
- 10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
- 10.1.1.7.3.1 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
- 10.1.1.7.3.2 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
- 10.1.1.7.4 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
- 10.1.1.7.5 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
- 11. Asia Pacific Acute Pancreatitis Market–Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in the Asia Pacific Acute Pancreatitis Market
- 11.3 Inorganic Growth Strategies
- 11.3.1 Overview
- 11.4 Organic Growth Strategies
- 11.4.1 Overview
- 12. Company Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 GE HealthCare Technologies Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Samsung Healthcare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Dynavax Technologies Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Fresenius Kabi AG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Boston Scientific Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 13. Appendix
- 13.1 About Us
- 13.2 Glossary of Terms
- LIST OF TABLES
- Table 1. Asia Pacific Acute Pancreatitis Market Segmentation
- Table 2. Asia Pacific Acute Pancreatitis Market, by Medications – Revenue and Forecast to 2030 (US$ Million)
- Table 3. Asia Pacific Acute Pancreatitis Market, by Diagnosis – Revenue and Forecast to 2030 (US$ Million)
- Table 4. China: Asia Pacific Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 5. China: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 6. China: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 7. China: Asia Pacific Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
- Table 8. China: Asia Pacific Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
- Table 9. Japan: Asia Pacific Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 10. Japan: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 11. Japan: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 12. Japan: Asia Pacific Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
- Table 13. Japan: Asia Pacific Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
- Table 14. India: Asia Pacific Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 15. India: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 16. India: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 17. India: Asia Pacific Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
- Table 18. India: Asia Pacific Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
- Table 19. Australia: Asia Pacific Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 20. Australia: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 21. Australia: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 22. Australia: Asia Pacific Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
- Table 23. Australia: Asia Pacific Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
- Table 24. South Korea: Asia Pacific Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 25. South Korea: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 26. South Korea: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 27. South Korea: Asia Pacific Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
- Table 28. South Korea: Asia Pacific Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
- Table 29. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 30. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 31. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
- Table 32. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
- Table 33. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
- Table 34. Recent Inorganic Growth Strategies in the Asia Pacific Acute Pancreatitis Market
- Table 35. Recent Organic Growth Strategies in the Asia Pacific Acute Pancreatitis Market
- Table 36. Glossary of Terms, Asia Pacific Acute Pancreatitis Market
- LIST OF FIGURES
- Figure 1. Asia Pacific Acute Pancreatitis Market Segmentation, By Country
- Figure 2. Asia Pacific Acute Pancreatitis Market - Key Industry Dynamics
- Figure 3. Impact Analysis of Drivers and Restraints
- Figure 4. Asia Pacific Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
- Figure 5. Asia Pacific Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
- Figure 6. Medications: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 7. Diagnosis: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 8. Others: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 9. Asia Pacific Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
- Figure 10. Gallstones: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 11. Alcoholism: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 12. Genetic Disorders: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 13. Infections: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 14. Others: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 15. Asia Pacific Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
- Figure 16. Hospitals: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 17. Diagnostic Laboratories: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 18. Ambulatory Surgical Centers: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 19. Others: Asia Pacific Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
- Figure 20. Asia Pacific Acute Pancreatitis Market, by Key Country – Revenue, 2022 (US$ Million)
- Figure 21. Asia Pacific Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
- Figure 22. China: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- Figure 23. Japan: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- Figure 24. India: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- Figure 25. Australia: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- Figure 26. South Korea: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- Figure 27. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
- Figure 28. Growth Strategies in the Asia Pacific Acute Pancreatitis Market
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook